Evaluating the life-extending potential and safety profile of rapamycin: a Mendelian Randomization study of the mTOR pathway
View ORCID ProfileMaria K Sobczyk, View ORCID ProfileTom R Gaunt
doi: https://doi.org/10.1101/2023.10.02.23296427
Maria K Sobczyk
1MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom
Tom R Gaunt
1MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom
Posted October 02, 2023.
Evaluating the life-extending potential and safety profile of rapamycin: a Mendelian Randomization study of the mTOR pathway
Maria K Sobczyk, Tom R Gaunt
medRxiv 2023.10.02.23296427; doi: https://doi.org/10.1101/2023.10.02.23296427
Subject Area
Subject Areas
- Addiction Medicine (324)
- Allergy and Immunology (633)
- Anesthesia (168)
- Cardiovascular Medicine (2404)
- Dermatology (207)
- Emergency Medicine (381)
- Epidemiology (11802)
- Forensic Medicine (10)
- Gastroenterology (705)
- Genetic and Genomic Medicine (3771)
- Geriatric Medicine (350)
- Health Economics (637)
- Health Informatics (2410)
- Health Policy (940)
- Hematology (342)
- HIV/AIDS (787)
- Medical Education (369)
- Medical Ethics (105)
- Nephrology (402)
- Neurology (3526)
- Nursing (199)
- Nutrition (529)
- Oncology (1835)
- Ophthalmology (540)
- Orthopedics (222)
- Otolaryngology (287)
- Pain Medicine (234)
- Palliative Medicine (67)
- Pathology (447)
- Pediatrics (1039)
- Primary Care Research (424)
- Public and Global Health (6187)
- Radiology and Imaging (1293)
- Respiratory Medicine (832)
- Rheumatology (380)
- Sports Medicine (324)
- Surgery (407)
- Toxicology (50)
- Transplantation (172)
- Urology (147)